Market and Trading Information for Applied Therapeutics
The following details were available for trading and market data about the stock of Applied Therapeutics as of writing:
Trading Details of Applied Therapeutics (APLT)
Current Share Price:
$5.06
Previous Year's Closing Price:
$3.35
Percentage Price Change (YTD):
51.04%
Market Cap:
$546.37 million
52-week Price Range:
$0.85 - $9.39
Dividend Per Share:
$0
EPS (TTM):
-1.42
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-12.97
Company Profile and Business Description for Applied Therapeutics
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinica...to see full details, pleaseLogin / Register to view.
ETFs Holding Applied Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Applied Therapeutics stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Applied Therapeutics stock holding. There are a total of 13 ETFs in Fknol.com records which are holding Applied Therapeutics stock in their portfolio. See Full List.
The Invesco DWA SmallCap Momentum ETF tracks an index of 200 small-cap securities with the best relative strength indicators; these indicators are determined by Dorsey Wright's proprietary methodology. ...Full Details
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
The iShares Microcap ETF tracks a market-cap-weighted index of U.S. micro-cap stocks. The index selects the smallest 1000 stocks in the Russell 2000 Index. ...Full Details
The iShares Russell 2000 ETF tracks a market-cap-weighted index of US small-cap stocks. The index selects stocks ranked 1,001-3,000 by market cap. ...Full Details ...Candlestick Patterns.
The iShares Russell 2000 Value ETF tracks an index of US small-cap-value stocks. The index selects value stocks from a universe of stocks ranked 1001-3000 by market cap. ...Full Details
The iShares Russell 2000 Growth ETF tracks a market-cap-weighted index of US small-cap growth stocks. The index selects from stocks ranked 1001-3000 by market cap based on two growth factors. ...Full Details
The iShares Russell 3000 ETF tracks a cap-weighted index that measures the investable US equities market, covering the entire market-cap spectrum, including micro-caps. ...Full Details
The Vanguard Russell 3000 ETF tracks a cap-weighted index that measures the investable US equities market, covering the entire market-cap spectrum including micro-caps. ...Full Details
The Vanguard Total Stock Market ETF tracks a cap-weighted index that measures the investable US equities market, encompassing the entire market-cap spectrum. ...Full Details ...Candlestick Patterns.
The Vanguard Russell 2000 Growth Index Fund tracks an index of US small-cap growth stocks. The index selects from stocks ranked 1001-3000 by market cap based on EPS growth estimates and historical sales growth. ...Full Details
See Full List of ETFs holding Applied Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Biotechnology Sector
Along with Applied Therapeutics Inc., the following other peer (competitor) companies also exist within the same Biotechnology - Healthcare sector whose company profile and dividend history is as follows:
▶ 180 Life Sciences Corp. (ATNF): 180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain,....See Detailed Company Profile, Dividend History
▶ 4D Molecular Therapeutics, Inc. (FDMT): 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It....See Detailed Company Profile, Dividend History
▶ 4D pharma plc (LBPS): 4D pharma plc, together with its subsidiaries, engages in the research, development, and production of live biotherapeutic products. The company develops....See Detailed Company Profile, Dividend History
▶ 60 Degrees Pharmaceuticals (SXTP): 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and....See Detailed Company Profile, Dividend History
▶ 89Bio (ETNB): 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 that is being developed for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treat....See Detailed Company Profile, Dividend History
▶ 9 Meters Biopharma, Inc. (NMTR): 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline....See Detailed Company Profile, Dividend History
▶ Aadi Bioscience, Inc. (AADI): Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with....See Detailed Company Profile, Dividend History
▶ Abcam plc (ABCM): Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in....See Detailed Company Profile, Dividend History
▶ AbCellera Biologics Inc. (ABCL): AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of....See Detailed Company Profile, Dividend History
▶ Abivax SA (ABVX): ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the bodys natural regulatory mechanisms....See Detailed Company Profile, Dividend History
▶ Absci Corporation (ABSI): Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation....See Detailed Company Profile, Dividend History
▶ ABVC Biopharma, Inc. (ABVC): American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in....See Detailed Company Profile, Dividend History
▶ Acelyrin (SLRN): Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative....See Detailed Company Profile, Dividend History
▶ Aceragen (ACGN): Aceragen, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare pulmonary and....See Detailed Company Profile, Dividend History
▶ Achilles Therapeutics plc (ACHL): Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid....See Detailed Company Profile, Dividend History
▶ ACRIVON THERAPEUTICS INC (ACRV): Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The companys lead clinical candidate is....See Detailed Company Profile, Dividend History
▶ Acumen Pharmaceuticals, Inc. (ABOS): Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimers and....See Detailed Company Profile, Dividend History
▶ Acurx Pharmaceuticals, Inc. (ACXP): Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate....See Detailed Company Profile, Dividend History
▶ Adagene Inc. (ADAG): Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers.....See Detailed Company Profile, Dividend History
▶ Adagio Therapeutics, Inc. (ADGI): Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based....See Detailed Company Profile, Dividend History